Atlas Trials

PSA Progression

18 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch PSA Progression

RecordFirmDate
White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA (NCT04519879)City of Hope Medical Center2021-05-10
Gallium Ga 68 DOTA-NeoBOMB1 and Gallium Ga 68 PSMA-R2 PET/MRI in Diagnosing Participants With Recurrent Prostate Cancer (NCT03698370)Andrei Iagaru2020-12-15
Apalutamide With or Without Stereotactic Body Radiation in Treating Castration-Resistant Prostate Cancer (NCT03503344)University of California, San Francisco2019-12-17
sEphB4-HSA in Treating Patients With Metastatic Castration-Resistant Prostate Cancer (NCT04033432)Northwestern University2019-09-20
Enzalutamide With Venetoclax in Treating Patients With Metastatic Castration Resistant Prostate Cancer (NCT03751436)Roswell Park Cancer Institute2019-08-02
Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery (NCT03541850)Jonsson Comprehensive Cancer Center2019-01-29
Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency (NCT03442556)University of Washington2018-08-24
Pembro and HER2Bi-Armed Activated T Cells in Treating Patients With Metastatic Castration Resistant Prostate Cancer (NCT03406858)Barbara Ann Karmanos Cancer Institute2018-06-07
68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer (NCT04050215)Jonsson Comprehensive Cancer Center2018-04-02
ESK981 in Treating Patients With Metastatic Castrate-Resistant Prostate Cancer (NCT03456804)Barbara Ann Karmanos Cancer Institute2018-03-08
Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer (NCT02703623)M.D. Anderson Cancer Center2016-05-18
Docetaxel and Carboplatin in Treating Patients With Metastatic, Castration Resistant Prostate Cancer Containing Inactivated Genes in the BRCA 1/2 Pathway (NCT02598895)University of Washington2016-01-26
Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide (NCT02312557)OHSU Knight Cancer Institute2014-11-18
Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Castration-Resistant Prostate Cancer (NCT02215161)University of California, San Francisco2014-09-02
Molecular Features and Pathways in Predicting Drug Resistance in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide (NCT02228265)OHSU Knight Cancer Institute2013-03-12
F18 DCFPyL PET/CT in Imaging Participants With Recurrent Prostate Cancer (NCT03501940)Andrei Iagaru

Track PSA Progression automatically

Every clearance here is in the API, with alerts when new ones post.